Title:
AZACYCLIC DERIVATIVE AND MEDICAL APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/143424
Kind Code:
A1
Abstract:
The present invention relates to a compound as represented by general formula (I) or a stereoisomer, a tautomer, a deuterated substance, a solvate, a prodrug, a metabolite, a pharmaceutically acceptable salt, or an eutectic thereof, an intermediate thereof, a preparation method therefor, and an application in the preparation of a pharmaceutical for treating a disease related to USP1 activity or expression.
More Like This:
| WO/2005/084401 | ARYL SUBSTITUTED PURINE ANALOGUES |
| WO/2005/063766 | BICYCLIC HETEROCYCLIC P-38 KINASE INHIBITORS |
| WO/2023/220402 | ENPP1 MODULATORS AND PRODUCTS AND USES THEREOF |
Inventors:
ZHANG CHEN (CN)
WANG JIANMIN (CN)
HUANG ZHENGGANG (CN)
QIAN GUOFEI (CN)
YU YAN (CN)
TANG PINGMING (CN)
LI YAO (CN)
YAN PANGKE (CN)
WANG JIANMIN (CN)
HUANG ZHENGGANG (CN)
QIAN GUOFEI (CN)
YU YAN (CN)
TANG PINGMING (CN)
LI YAO (CN)
YAN PANGKE (CN)
Application Number:
PCT/CN2023/073285
Publication Date:
August 03, 2023
Filing Date:
January 20, 2023
Export Citation:
Assignee:
SICHUAN HAISCO PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D487/04; A61K31/519; A61P35/00
Domestic Patent References:
| WO2022216820A1 | 2022-10-13 | |||
| WO2017136309A1 | 2017-08-10 | |||
| WO2017200087A1 | 2017-11-23 | |||
| WO2018111795A2 | 2018-06-21 | |||
| WO2020086650A2 | 2020-04-30 | |||
| WO2020176761A1 | 2020-09-03 |
Foreign References:
| CN113164485A | 2021-07-23 | |||
| CN109438447A | 2019-03-08 |
Attorney, Agent or Firm:
WU , FENG & ZHANG (CN)
Download PDF: